- Topics
- Aerospace
- Animals
- Anthro and Archaeology
- Bio and Medicine
- Brain and Behavior
- Business and Economy
- Computers and Electronics
- Education and Outreach
- Energy and Environment
- Geoscience
- Internet and Communication
- Media and Entertainment
- Nanotech, Chem and Materials
- Physics and Numbers
- Security and Defense
- Software
- Space
- Transportation
- Reader Blogs
- Commerce
- Register/Login
- RSS
Bio and Medicine
Unsuccessful drug against anxiety opens a novel gateway for the treatment of cancer
Cancer cells have multiple ways to avoid apoptosis, programmed cell death the means by which organisms deal with defective cells. One defense is to produce quantities of phosphatic acid, a phospholipid constituent of cellular membranes.
- Add new comment
- Read more
- 355 reads
Living donor liver transplants may drastically decrease mortality from liver failure
Patients with acute liver failure (ALF) could be saved by a transplant from a living donor (LDLT), according to a new study in the September issue of Liver Transplantation, a journal by John Wiley & Sons. The recent experience of U.S. patients shows that recipient mortality rates and donor morbidity rates are acceptable.
- Add new comment
- Read more
- 204 reads
Molecular evolution is echoed in bat ears
Bats' ability to echolocate may have evolved more than once, according to research published this week by Queen Mary, University of London scientists.
- 2 comments
- Read more
- 278 reads
Female orgasm ability related to walking style
A new study found that trained sexologists could infer a woman's history of vaginal orgasm by observing the way she walks.
- 4 comments
- Read more
- 4414 reads
Spine-Relaxing Chairs Invented
Russian engineers from Belgorod have invented new type of chairs, allowing reducing spinal strain significantly, thus avoiding spine’s deformations, which often occur, when one leads a sedentary life.
- russianscience's blog
- 3 comments
- Read more
- 284 reads
Cystic Fibrosis – Axentis Pharma Initiates Clinical Trial for Lung Infections
Zurich, 4. September 2008. Axentis Pharma AG has initiated a clinical phase
IIa trial to assess the safety and tolerability of a new therapeutic
formulation for the treatment of severe pulmonary infection in cystic
fibrosis patients. The new formulation allows an established therapeutic
agent to be delivered directly to the site of infection. The forthcoming
trial will also compare the effects of two different doses of the new drug.
Initial results are expected in summer 2009. Axentis Pharma acquired all the
necessary rights for this formulation from international partners just eight
months ago. In addition to these advances, the company has also succeeded in
appointing two renowned experts to its Scientific Advisory Board.
- prandd's blog
- Add new comment
- Read more
- 190 reads
Study Shows Antibiotic Cycling Reduces Hospital MSRA Deaths
Doctors at the University of Virginia Health System have significantly reduced MRSA infections among surgical intensive care patients by using antibiotic cycling, a method of rotating drugs at regular intervals.
- Add new comment
- Read more
- 384 reads
Scientists Find Our Eyes Evolved for 'X-Ray' Vision
The advantage of using two eyes to see the world around us has long been associated solely with our capacity to see in three dimensions. Now, a new study has uncovered a truly eye-opening advantage to binocular vision: the ability to see through things.
DNA editing tool flips its target
Imagine having to copy an entire book by hand without missing a comma. Our cells face a similar task every time they divide. They must duplicate both their DNA and a subtle pattern of punctuation-like modifications on the DNA known as methylation.
Scientists uncover Ebola cell-invasion strategy
University of Texas Medical Branch at Galveston researchers have discovered a key biochemical link in the process by which the Ebola Zaire virus infects cells — a critical step to finding a way to treat the deadly disease produced by the virus.
- Add new comment
- Read more
- 260 reads

